Research programme: anti-hepatitis C virus monoclonal antibodies - GENimmune

Drug Profile

Research programme: anti-hepatitis C virus monoclonal antibodies - GENimmune

Alternative Names: ED 004; GNI 104; HCV hu mAbs - GENimmune

Latest Information Update: 14 Oct 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GENimmune
  • Class Monoclonal antibodies
  • Mechanism of Action Immunomodulators; Virus internalisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hepatitis C

Most Recent Events

  • 12 Feb 2008 Discontinued - Preclinical for Hepatitis C in Belgium (Parenteral)
  • 11 Dec 2007 A lead monoclonal antibody receives orphan drug status from the European Commission for the prevention of hepatitis C virus re-infection after liver transplantation
  • 28 Nov 2007 This programme is available for licensing (
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top